September 5, 2021Open Access

Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction

Structured PICO

Do biomarker concentrations predict long-term outcomes differently in STEMI versus NSTEMI patients?

Population

Patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI)

Intervention

Biomarker concentration measurement

Comparator

STEMI vs NSTEMI

Outcome

Long-term outcome

Biomarkers have similar prognostic value in STEMI and NSTEMI patients, suggesting they should not be used to differentiate treatment strategies between these groups.

Abstract

In the acute setting, biomarkers indicated greater myocardial dysfunction and inflammation in STEMI, whereas they displayed a more diverse pathophysiologic pattern in NSTEMI patients. These biomarkers were similarly prognostic in STEMI and NSTEMI patients. The results do not support treating STEMI and NSTEMI patients differently based on the concentrations of these biomarkers.

Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction

Structured PICO

Abstract

Cite This Study

Also Consider

Also Consider